logo
Share SHARE
FONT-SIZE Plus   Neg

Teva Commences Launch Of Irbesartan And Irbesartan-hydrochlorothiazide Tablets

Generic drugmaker Teva Pharmaceutical Industries Ltd. (TEVA) Monday said it has commenced commercial launch of both irbesartan and irbesartan-hydrochlorothiazide tablets, the company's generic versions of Sanofi Aventis' high blood pressure treatments, Avapro and Avalide tablets.

The brand products had annual sales of around $464 million and $124 million, respectively, in the U.S., based on IMS sales data.

As the first company to file Abbreviated New Drug Applications containing paragraph IV certifications for both of these products, Teva has been awarded a 180-day period of marketing exclusivity.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
China has largely blocked instant messaging service WhatsApp, the media reported. The disruption is said to be the latest step to tighten censorship as the country prepares for the Communist Party's congress in Beijing, which starts October 18. Walt Disney Co. has threatened to pull its programming from cable distributor Altice USA Inc. if the two companies are unable to reach a new deal before the end of September. The current contract between the two companies expires at the end of this month. Jaguar Land Rover, Britain's biggest car maker, is eyeing potential acquisitions of international automakers, Bloomberg reported Monday, citing people with knowledge of the matter. Jaguar Land Rover, owned by India's Tata Motors Ltd., has reportedly been holding internal discussion on acquiring other brands in order to diversify its range of vehicles.
comments powered by Disqus
Follow RTT